Sangamo BioSciences, Inc.

Award Value
Strategic Partnership II: Fyodor Urnov A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells $6,374,150
Total:
$6,374,150.00
Icon for xls export